Toward evidence-based decisions in diagnostic radiology: a research and rating process for multiple decision-makersDaniel A Ollendorf
Institute for Clinical and Economic Review, Massachusetts General Hospital, Boston, 02114, USA
Acad Radiol 19:1049-54. 2012
..The issues raised, controversies considered, and use of the ratings in setting policy are discussed in relation to each example...
- Differences in annual medication costs and rates of dosage increase between tumor necrosis factor-antagonist therapies for rheumatoid arthritis in a managed care population
Daniel A Ollendorf
IMS Health, Inc, Norwalk, Connecticut, USA
Clin Ther 31:825-35. 2009
..Tumor necrosis factor (TNF) antagonists are commonly used to treat rheumatoid arthritis (RA). Differences in the dosage and mode of administration of these agents may result in differential rates of dosage adjustment and costs of care...
The diagnostic performance of multi-slice coronary computed tomographic angiography: a systematic reviewDaniel A Ollendorf
Institute for Clinical and Economic Review, Boston, MA, USA
J Gen Intern Med 26:307-16. 2011
....
Impact of co-prescribed glatiramer acetate and antihistamine therapy on the likelihood of relapse among patients with multiple sclerosisDaniel A Ollendorf
Institute for Clinical and Economic Review, Boston, MA, USA
J Neurosci Nurs 40:281-90. 2008
..962, 95% CI = 0.675, 1.373). In conclusion, our findings indicate that concomitant use of prescription AHs with GA therapy does not appear to significantly affect the risk of relapse among patients with multiple sclerosis...
- Impact of leflunomide versus biologic agents on the costs of care for rheumatoid arthritis in a managed care population
Daniel A Ollendorf
Analytic and Consulting Services, PharMetrics, Inc, Watertown, Massachusetts, USA
Am J Manag Care 8:S203-13. 2002
..Findings persisted in multivariate analyses of cost. CONCLUSIONS: Leflunomide is associated with reduced costs of medications and other healthcare services relative to biologic medications among managed care patients with RA...
- Patterns of use, dosing, and economic impact of biologic agent use in patients with rheumatoid arthritis: a retrospective cohort study
Thomas D Gilbert
Market Research, The Ipsen Group, Inc, 27 Maple Street, Milford, MA 01757, USA
BMC Musculoskelet Disord 5:36. 2004
..We examined dosing and costs among RA patients newly treated with infliximab or etanercept under conditions of typical clinical practice...
- Effect of initial ziprasidone dose on length of therapy in schizophrenia
Amie T Joyce
PharMetrics, Inc, 311 Arsenal Street, Watertown, MA 02472, USA
Schizophr Res 83:285-92. 2006
..To examine the effects of initial ziprasidone dose on discontinuation rates, using retrospective integrated medical and pharmacy claims data...
- End-stage renal disease-associated managed care costs among patients with and without diabetes
Amie T Joyce
Senior Research Consultant, PharMetrics, Inc, 311 Arsenal St, Watertown, MA 02472, USA
Diabetes Care 27:2829-35. 2004
..To examine the direct costs of care before and after onset of end-stage renal disease (ESRD) for patients with and without diabetes based on analyses of retrospective healthcare claims data...
- Active surveillance compared with initial treatment for men with low-risk prostate cancer: a decision analysis
Julia H Hayes
Lank Center for Genitourinary Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA
JAMA 304:2373-80. 2010
..Treatment of these cancers is associated with substantial morbidity. Active surveillance is an alternative to initial treatment, but long-term outcomes and effect on quality of life have not been well characterized...
- An integrated evidence rating to frame comparative effectiveness assessments for decision makers
Daniel A Ollendorf
Institute for Clinical and Economic Review ICER, Massachusetts General Hospital Institute for Technology Assessment, Boston, MA 02114, USA
Med Care 48:S145-52. 2010
....
- A simulation model of clinical and economic outcomes of cardiac CT triage of patients with acute chest pain in the emergency department
Alexander Goehler
Institute for Technology Assessment, Massachusetts General Hospital, Harvard Medical School, 101 Merrimac St, 10th Fl, Boston, MA 02114, USA
AJR Am J Roentgenol 196:853-61. 2011
..Our objective was to construct a simulation model to estimate clinical and economic outcomes...
- An examination of treatment patterns and costs of care among patients with benign prostatic hyperplasia
Libby Black
PharMetrics, Inc, 311 Arsenal Street, Watertown, MA 02472, USA
Am J Manag Care 12:S99-S110. 2006
..Strategies to prevent or delay the need for surgery, such as regular examinations, testing, and use of pharmacotherapy where indicated, may further reduce the need for surgical intervention...
- Burden of illness among commercially insured patients with Alzheimer's disease
Amie T Joyce
PharMetrics Inc a unit of IMS, Watertown, MA, USA
Alzheimers Dement 3:204-10. 2007
..CONCLUSIONS: The annual economic burden of AD to third-party payers is more substantial than previously estimated ($3,805 to $8,200)...
- Management strategies for attention-deficit/hyperactivity disorder: a regional deliberation on the evidence
Sarah K Emond
Institute for Clinical and Economic Review, MGH Institute for Technology Assessment, Boston, MA 02114, USA
Postgrad Med 124:58-68. 2012
..The ADHD CEPAC meeting demonstrated the important role that a public, transparent deliberation on the latest medical evidence can have in supporting informed decision making and efficient use of health care resources...
- Rate of new-onset diabetes among patients treated with atypical or conventional antipsychotic medications for schizophrenia
Daniel A Ollendorf
Analytic and Consulting Services, PharMetrics, Inc, Watertown, Massachusetts, USA
MedGenMed 6:5. 2004
..Understanding the association between use of antipsychotics and onset of diabetes...
